The Board of Directors of Oriental Holdings Berhad announced that the incorporation of a wholly owned subsidiary company known as Star Life Pharma Sdn Bhd under the Companies Act 2016, Malaysia on 22 January 2019. The initial issued share capital of Star Life Pharma is One Ordinary Share at an issue price of Ringgit Malaysia One only. The issued capital of Star Life Pharma will be increased as and when necessary. The intended principal activity of Star Life Pharma is to operate an integrated lifestyle retail pharmacy with a comprehensive range of products and services.